North America Home Infusion Therapy Market Size, Share & Trends Analysis Report By Type (Products, Services), By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals) and By Country (US, Canada) Forecasts, 2026-2034

Market Overview

An alternative to taking medication by mouth is infusion therapy, which is how the term is defined. The infusion process involves monitoring the administration of medication with the assistance of a sterile catheter inserted into a vein. Home infusion therapy refers to giving an individual medication or biologicals through an intravenous or subcutaneous route while they live in their residence. The medication (such as antivirals or immune globulin, for example), the necessary piece of medical equipment (such as a pump), and the necessary medical supplies

are required to carry out home infusion (for example, tubing and catheters). In a similar vein, nursing services must educate and train both the patient and the caregivers administering the infusion medications in the patient's home. Home infusion treatment frequently requires a significant contribution from visiting nurses. Typically, nurses will instruct the patient or the caregiver on how to self-administer the medication, educate the patient about the potential adverse effects of the treatment and the aims of therapy, and visit the patient occasionally to evaluate the infusion site and change the dressing. In most cases, the procedure of home infusion needs coordination among several different parties. These parties can include patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if necessary, home health organisations.

Market Dynamics

Drivers

Increasing Preference for Home Therapy

Home infusion therapy has many advantages. They are more convenient, less expensive, produce better results, and adhere to higher safety standards. Home infusion therapy is less expensive than hospital treatment because it eliminates hospital stays, saving patients money. It also allows the patient to maintain a higher level of safety at home because there is less risk of hospital-acquired infections.

The growing preference of patients for home therapy is also propelling the growth of the home infusion therapy market in North America. Home healthcare helps patients with their daily activities and provides better access to skilled medical care and advanced healthcare services. Furthermore, geriatric patients with chronic diseases and individuals recently discharged from hospitals and other healthcare settings are expected to be at high nutritional risk and can benefit from home-cooked meals. These factors are presumed to drive market growth during the forecast period.

Growing Developments in the Home Healthcare Industry

Growing advancements in the in-home healthcare industry are also expected to fuel market growth in the coming years. Point-of-care (POC) diagnostics that aid in faster patient care and telehealth programmes for patients suffering from chronic disorders who require frequent admission are on the rise. In 2021, the pandemic had a positive impact on the market. As McKinsey shows, emergency room visits in the United States are down by half or more and are expected to continue declining. This prompted healthcare providers to prescribe patients home infusion treatments to remotely monitor them, which is safe for the patient and reduces the burden on a healthcare facility.

Restraints

Occupational Safety and Health (osh) Challenges in Home Health Care (hhc) Work

OSH hazards in HHC include exposure to bloodborne pathogens (BBP) but are not limited to only that. It also includes demanding patient mobilisation and transfer tasks, violence and other personal safety issues, exposure to second-hand tobacco smoke, cleaning and other household chemicals, long-distance driving, and the presence of pets. OSH hazards in HHC also include, but are not limited to, exposures to cleaning and other household chemicals. Some of these dangers can be found in any health care setting; however, home-based carers often work alone in circumstances that can be very changeable and unpredictable can heighten their susceptibility to these dangers.

North America Home Infusion Therapy Market Segmentation Analysis

By Type

The North America Home Infusion Therapy Market is segmented into Products and Services. Products include infusion pumps, intravenous administration sets, IV cannulas, needleless connectors, and other medical supplies used to administer medications, fluids, nutrients, and specialty therapies in home settings. Services include nursing care, therapy management, patient education, monitoring, coordination, and clinical support required for safe and effective home infusion treatment. Increasing preference for home-based healthcare, rising prevalence of chronic diseases, aging populations, and the need to reduce hospital stays are supporting demand for both products and services, while expanding home healthcare programs are increasing the importance of coordinated clinical support.

Technological advancements in infusion devices, growing healthcare expenditure, increasing patient preference for convenient treatment, and expansion of outpatient care are creating opportunities across both segments. Product demand is supported by the need for reliable, portable, and easy-to-use infusion equipment and consumables, while service providers are benefiting from the growing requirement for professional supervision and long-term patient support. Increasing adoption of home infusion programs, remote monitoring technologies, and specialized home healthcare services is expected to strengthen the transition from hospital-based treatment to home-based care across North America.

Request Customizationto receive a tailored report.

By Product

The North America Home Infusion Therapy Market is segmented into Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors. Infusion pumps enable controlled and accurate delivery of medications, fluids, and nutrients and are particularly important for therapies requiring precise administration rates. Intravenous sets facilitate the delivery of infusion solutions, while IV cannulas provide vascular access for intravenous treatment. Needleless connectors enable safer connections between infusion components and help reduce the need for repeated needle access. Product selection depends on therapy type, treatment duration, patient condition, infusion volume, and clinical requirements.

Growing adoption of home-based treatment, increasing prevalence of chronic and infectious diseases, rising demand for portable medical technologies, and expansion of home healthcare services are supporting demand across all product categories. Infusion pumps are gaining importance because of their programmable and controlled administration capabilities, while intravenous sets, IV cannulas, and needleless connectors benefit from the increasing number of patients requiring repeated or long-term infusion therapy. Continued product innovation, increasing focus on patient safety, and the need to simplify home-based treatment are expected to create further opportunities for infusion therapy product manufacturers across North America.

By Application

The North America Home Infusion Therapy Market is segmented into Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, and Specialty Pharmaceuticals. Anti-infective therapy is used for patients requiring prolonged treatment, while endocrinology applications include therapies requiring regular medication administration and monitoring. Hydration therapy provides fluids and electrolytes to patients requiring fluid replacement, while selected chemotherapy treatments can be administered in home settings under appropriate clinical supervision. Enteral and parenteral nutrition support patients who cannot obtain sufficient nutrition through normal oral intake, while specialty pharmaceuticals include complex therapies requiring specialized administration and monitoring.

Rising prevalence of chronic diseases, increasing demand for convenient treatment options, aging populations, and efforts to reduce hospital utilization are supporting growth across these application areas. Anti-infective, hydration, and nutritional therapies are benefiting from the expansion of home healthcare, while specialty pharmaceuticals and selected chemotherapy applications are creating opportunities as healthcare providers develop more advanced home treatment programs. Increasing patient preference for receiving appropriate treatment in familiar home environments, improvements in infusion technology, remote monitoring capabilities, and the availability of specialized healthcare professionals are expected to support continued adoption across these applications.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The North America home infusion therapy market is divided into the U.S., Canada, & Mexico based on the country. North America holds a significant share in the home infusion therapy market, owing to rising chronic disease prevalence, treatment costs, technological advancements, and product launches expected to drive regional growth. The Canadian Cancer Society claims an estimated 225,800 new cancer cases will be diagnosed in 2020, with an estimated 83,300 cancer deaths in Canada.

Furthermore, the American Cancer Society claims that for 2019, approximately 1,762,450 new cancer cases were diagnosed and 606,880 cancer deaths in the United States. Breast cancer, lung cancer, prostate cancer, colorectum cancer, bladder cancer, and skin cancer are the most common cancers in the United States.

List of Key and Emerging Players in North America Home Infusion Therapy Market

• Braun Melsungen
• Baxter International
• Caesarea Medical Electronics Ltd.
• CareFusion
• Fresenius Kabi
• ICU Medical
• JMS CO., LTD.
• Smiths’ Medical, Inc.
• Terumo Corporation
• Coram LLC
• Option Care Enterprises, Inc.
• BioScrip, Inc.
• BriovaRx Infusion Services
• Paragon Healthcare